History of the HIV Research Trust
The International Congress on Drug Therapy in HIV Infection was set up in 1992. The Scientific Committee decided that unspent funds should be transferred to a charity whose remit was to support researchers in resource-limited countries in obtaining further training and expertise in developing their research programmes. The HIV Research Trust (HIVRT) was established and four appointing bodies were agreed: University College London Medical School UK, The Karolinska Institute Sweden, The Amsterdam Medical Centre The Netherlands and The International AIDS Society Italy. Trustees were appointed to oversee the allocation of the funding of competitive scholarships open to researchers in all specialties concerned with HIV infection. The International Congress on Drug Therapy in HIV Infection also links to a web based resource providing health care professionals with emerging data, clinical updates, meeting reviews and latest news in HIV drug therapies and this can be found at www.hivdrugtherapy.org The HIVRT works in partnership with the International Aids Society (IAS) in advertising the scholarships.
Aims of the HIV Research Trust
The HIV Research Trust aims to support a broad mix of disciplines. The scholarships are for physicians, nurses, scientists, and other health care professionals in resource-limited settings. The Trust supports early/mid career researchers. The award should develop a candidate’s career and, on return to the home institution, add to the capacity of the department to carry out research related to treatment and prevention. Examples of acquired skills might be; clinical trial experience, good clinical trial practice, data and trial management, acquisition of laboratory techniques and analyses, trial nurse skills, statistical expertise, aspects of ethics, economics, education and health behaviour